CMS Energy(CMS)
Search documents
CMS Energy Announces Strong Third Quarter Results, Raises 2025 Adjusted EPS, Initiates 2026 Guidance
Prnewswire· 2025-10-30 10:30
Core Insights - CMS Energy reported earnings per share of $0.92 for Q3 2025, an increase from $0.84 in Q3 2024, with adjusted earnings per share at $0.93 compared to $0.84 in the same quarter last year [1][2] - For the first nine months of 2025, the company reported earnings per share of $2.59, up from $2.45 in 2024, with adjusted earnings per share at $2.66 compared to $2.47 in 2024, attributed to favorable regulatory outcomes and weather conditions [1][2] Financial Performance - Operating revenue for Q3 2025 was $2.021 billion, compared to $1.743 billion in Q3 2024, while operating expenses increased to $1.540 billion from $1.376 billion [6] - Net income for Q3 2025 was $272 million, up from $247 million in Q3 2024, with net income available to common stockholders at $275 million compared to $251 million in the previous year [6][7] - The company raised its 2025 adjusted earnings guidance to a range of $3.56 to $3.60 per share and initiated 2026 adjusted earnings guidance of $3.80 to $3.87 per share [2] Strategic Outlook - CMS Energy's long-term adjusted EPS growth is reaffirmed at 6 to 8 percent, with confidence towards the high end of this range [2] - The company emphasizes its strong track record of constructive regulatory outcomes, particularly in natural gas rate cases and renewable energy plans [2] Cash Flow and Capitalization - Net cash provided by operating activities for the nine months ended September 30, 2025, was $1.757 billion, while net cash used in investing activities was $(2.926) billion [7] - Total assets as of September 30, 2025, were $38.008 billion, an increase from $35.920 billion at the end of 2024 [6]
Consumers Energy Foundation Announces $500,000 for Community Projects in Northern Michigan
Prnewswire· 2025-10-29 12:00
Core Points - The Consumers Energy Foundation announced its 2025 Prosperity Award Winners, granting a total of $500,000 to projects in Curtis Township, Lincoln Township, and the Village of Vanderbilt aimed at economic development and community welfare [1][2] - The Foundation's Prosperity Awards are part of its annual grant rounds, with a total allocation of $1.5 million in 2025, following previous awards in April and July [3][4] Group 1: Award Recipients and Projects - Curtis Township received $250,000 to revitalize a vacant downtown building into a hub for community events and local government meetings, enhancing civic engagement [5] - Lincoln Township was awarded $150,000 for the Bertha's New Beat project, which aims to improve accessibility and inclusivity at Bertha Lake Park through various enhancements [5] - The Village of Vanderbilt received $100,000 for the Gateway to the Pigeon River project, creating an inviting entrance to the community and promoting tourism and local economic growth [5] Group 2: Foundation's Mission and Contributions - The Consumers Energy Foundation focuses on strengthening Michigan communities by investing in people, the planet, and prosperity [4] - In 2024, the Foundation and its affiliates contributed over $15 million to support Michigan nonprofits and communities [4]
新浪财经ESG:CMS能源 MSCI(明晟)ESG评级调降至A
Xin Lang Cai Jing· 2025-10-15 23:04
Core Viewpoint - CMS Energy's MSCI ESG rating has been downgraded from AA to A as of October 15, 2025 [1] Group 1 - The downgrade reflects a change in the company's environmental, social, and governance performance metrics [1]
CMS Energy to Announce 2025 Third Quarter Results on October 30
Prnewswire· 2025-10-14 20:30
Group 1 - CMS Energy will provide its 2025 third quarter results along with a business and financial outlook on October 30, 2025, at 9:30 a.m. EDT [1] - A webcast of the presentation will be available on CMS Energy's website, and an audio replay will be accessible approximately three hours after the webcast, archived for 30 days [1] Group 2 - CMS Energy is a Michigan-based energy company, with Consumers Energy as its primary business, and it also operates independent power generation businesses [2] - For further information, CMS Energy's website can be visited, and email alert notifications can be signed up for in the Investor section [2]
CMS Energy Corporation (CMS) Energy Corporation - Special Call - Slideshow (NYSE:CMS) 2025-10-06
Seeking Alpha· 2025-10-06 15:30
Group 1 - The article does not provide any specific content related to a company or industry [1]
Primech Holdings' HYTRON Draws 250+ Qualified Client Inquiries at CMS Berlin 2025, Signaling Global Expansion
Globenewswire· 2025-09-29 12:35
Core Insights - Primech AI Pte. Ltd. has gained significant global traction from its participation at CMS Berlin 2025, showcasing its next-generation HYTRON AI robots for sustainable hygienic service, resulting in over 250 qualified client inquiries [1][2][3] - The strong interest from international hotel chains and strategic partners across Europe, the USA, the Middle East, Australia, and Japan indicates robust global demand and business development opportunities in the facility management sector [2][3] Company Overview - Primech AI is a leading robotics company focused on innovation in technology, aiming to revolutionize the robotics industry with impactful solutions [4] - Primech Holdings Limited, headquartered in Singapore, provides comprehensive technology-driven facilities services, catering to both public and private sectors with a commitment to sustainability and advanced technology [5] Market Potential - The HYTRON robots demonstrated advanced AI capabilities and autonomous operations, delivering measurable efficiency gains and scalability in both commercial and household settings, highlighting the commercial potential in the multi-billion-dollar global facilities management market [1][2][3] - The launch of HYTRON's global World Tour aims to enhance visibility and accelerate commercialization, with upcoming events including the Building Maintenance & Clean Expo 2025 in Tokyo and CES Las Vegas [3]
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
Globenewswire· 2025-09-28 04:20
Core Viewpoint - China Medical System Holdings Limited (CMS) announced positive results from a phase 3 clinical trial of ruxolitinib cream for treating mild to moderate atopic dermatitis (AD) in China, indicating significant efficacy and safety of the product [1][3]. Clinical Trial Summary - The phase 3 clinical trial was a randomized, double-blind, placebo-controlled study involving 192 patients, led by Shanghai Dermatology Hospital [2]. - The trial met its primary endpoint, with 63.0% of patients achieving an Investigator's Global Assessment (IGA) score of 0 or 1 at week 8, compared to 9.2% in the placebo group (P<0.001) [3]. - For the key secondary endpoint, 78.0% of patients treated with ruxolitinib cream achieved at least a 75% improvement in the Eczema Area and Severity Index (EASI 75) score at week 8, versus 15.4% in the placebo group (P<0.001) [3]. - The treatment was found to be safe and well-tolerated, with most treatment-emergent adverse events being mild or moderate, and no discontinuations due to adverse events [3]. Product Development and Regulatory Status - CMS is advancing the new drug application (NDA) for ruxolitinib cream in China [4]. - The product has received approval for the treatment of non-segmental vitiligo in Hong Kong and Macau, and is also approved by the Guangdong Provincial Medical Products Administration [7]. - A collaboration and license agreement was established between CMS's subsidiary Dermavon and Incyte for the development and commercialization of ruxolitinib cream in various regions, including Mainland China and Southeast Asia [8][9]. Market Context for Atopic Dermatitis - Atopic dermatitis is a chronic inflammatory skin condition affecting over 54 million patients in China as of 2024, with 73% classified as mild and 25% as moderate [5]. - Traditional treatments like topical corticosteroids have limitations, highlighting the need for novel therapies such as ruxolitinib cream [5]. About Ruxolitinib Cream - Ruxolitinib cream (Opzelura®) is a selective JAK1/JAK2 inhibitor developed by Incyte, approved in the U.S. for non-segmental vitiligo and for mild to moderate AD in patients aged 2 and older [6].
Jim Cramer Says He Thinks CMS Energy is “Fine”
Yahoo Finance· 2025-09-24 08:28
Core Insights - CMS Energy Corporation (NYSE:CMS) is recognized for its electricity and natural gas services, utilizing diverse energy sources including coal, gas, wind, nuclear, and renewables [1] - The company has agreed to sell its 13 hydroelectric dams to Confluence Hydro, aiming to reduce long-term costs while ensuring safety and supporting local economic needs [1] Company Overview - CMS Energy operates extensive generation, transmission, and distribution networks, serving millions of residential, commercial, and industrial customers [1] - The company is involved in the development and operation of renewable energy projects [1] Recent Developments - The sale of the hydroelectric dams includes a 30-year power supply contract and is subject to regulatory approval [1] - The transaction is intended to transfer operations to a buyer focused on river hydro generation, as stated by the company's Vice President, Jean Kang [1]
Energy For Your Portfolio: How CMS Energy's Baby Bonds Fuel Yield (NYSE:CMS)
Seeking Alpha· 2025-09-22 21:19
Core Insights - CMS Energy Corporation (NYSE: CMS) is highlighted as a stable energy company with over a century of operational history, showcasing financial stability and attractive investment potential [1]. Company Overview - CMS Energy has a long-standing presence in the energy sector, indicating resilience and reliability in its operations [1]. Financial Performance - The article emphasizes the financial stability of CMS Energy, suggesting that it continues to impress investors with its performance metrics [1].
Jim Cramer: This Basic Materials Stock Has Gone Up So Much, Recommends Waiting For A 'Little Bit Of A Pullback'
Benzinga· 2025-09-22 12:09
Group 1: CMS Energy Corporation - CMS Energy Corporation reported better-than-expected earnings for the second quarter on July 31, leading to a recommendation from Jim Cramer to buy the stock [1] - CMS Energy shares fell 0.1% to settle at $70.12 on Friday [5] Group 2: Ramaco Resources, Inc. - Jim Cramer suggested waiting for a pullback on Ramaco Resources, Inc. due to its significant price increase [1] - Jefferies analyst Chris LaFemina maintained a Buy rating on Ramaco Resources and raised the price target from $27 to $45 [1] - Ramaco Resources shares fell 1.6% to close at $30.42 [5] Group 3: Accenture plc - Accenture disclosed the acquisition of IAMConcepts, a Canadian company specializing in identity and access management services, on September 9 [2] - Jim Cramer expressed a positive outlook on Accenture, stating "I don't think it's that bad" and indicated willingness to invest [2] - Accenture shares rose 0.1% to settle at $239.70 on Friday [5] Group 4: Okta, Inc. - Okta reported second-quarter revenue of $728 million, exceeding analyst estimates of $712.01 million, and adjusted earnings of 91 cents per share, beating estimates of 84 cents per share [3] - Jim Cramer expressed a favorable view of Okta, recommending it alongside mentioning PANW [2] - Okta shares fell 0.3% to $93.37 during the session [5] Group 5: Rocket Companies, Inc. - Jim Cramer recommended Wells Fargo over Rocket Companies, Inc. when asked about the latter [3] - On September 4, Rocket and the Bank of Montreal extended and expanded their existing Master Repurchase Agreement [3] - Rocket Companies shares fell 3% to close at $20.51 [5]